![Kazuhiro Umeda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kazuhiro Umeda
Directeur Général chez
M3i, Inc.
Profil
Kazuhiro Umeda currently works at M3i, Inc., as Chief Executive Officer from 2016, POC Clinical Research, Inc., as Director from 2015, PorMedTec Co., Ltd., as Director from 2017, and SIIF Impact Capital, Inc., as Fund Manager.
Mr. Umeda also formerly worked at A-CUBE, Inc., as Director, StemRIM, Inc., as Independent Outside Director from 2017 to 2020, Japan Asia Investment Co. Ltd. (Private Equity), as Manager from 2005 to 2007, and JAIC America, Inc., as Investment & Business Development Manager in 2010.
Mr. Umeda received his undergraduate degree and graduate degree from the University of Tokyo.
Postes actifs de Kazuhiro Umeda
| Sociétés | Poste | Début |
|---|---|---|
M3i, Inc.
 M3i, Inc. Investment ManagersFinance M3i invests in companies located in Japan. The firm focuses on the medical and healthcare sectors. It participates in seed, early, and later-stage transactions. | Directeur Général | 22/03/2016 |
POC Clinical Research, Inc.
 POC Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development support for medical technology and provides strategies | Directeur/Membre du Conseil | 01/10/2015 |
PorMedTec Co., Ltd.
 PorMedTec Co., Ltd. BiotechnologyHealth Technology Develops and tests genetically medical pigs | Directeur/Membre du Conseil | 01/12/2017 |
Anciens postes connus de Kazuhiro Umeda
| Sociétés | Poste | Fin |
|---|---|---|
| STEMRIM | Directeur/Membre du Conseil | 29/10/2020 |
JAIC America, Inc.
 JAIC America, Inc. Investment ManagersFinance JAIC America invests in companies located in the United States and Japan. The firm targets companies operating in the fields of mobile/communications, digital media, life science and cleantech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 30/10/2010 |
Japan Asia Investment Co. Ltd. (Private Equity)
 Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance JAIC invests in companies located in Japan. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements. | Corporate Officer/Principal | 31/12/2007 |
A-CUBE, Inc.
 A-CUBE, Inc. BiotechnologyHealth Technology Develops novel antibodies | Directeur/Membre du Conseil | - |
Formation de Kazuhiro Umeda
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Japan Asia Investment Co. Ltd. (Private Equity)
Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance JAIC invests in companies located in Japan. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements. | Finance |
JAIC America, Inc.
JAIC America, Inc. Investment ManagersFinance JAIC America invests in companies located in the United States and Japan. The firm targets companies operating in the fields of mobile/communications, digital media, life science and cleantech sectors. It provides financing for early stage capital requirements. | Finance |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology Develops novel antibodies | Health Technology |
StemRIM, Inc.
 StemRIM, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of regenerative drugs | Commercial Services |
M3i, Inc.
M3i, Inc. Investment ManagersFinance M3i invests in companies located in Japan. The firm focuses on the medical and healthcare sectors. It participates in seed, early, and later-stage transactions. | Finance |
POC Clinical Research, Inc.
POC Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development support for medical technology and provides strategies | Commercial Services |
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology Develops and tests genetically medical pigs | Health Technology |
